Franchise Future in Doubt After Box Office Disappointment
One of the most iconic horror franchises of the past two decades faces an uncertain future, with reports indicating the planned third installment of the 28 Years Later trilogy is now at serious risk of being axed. According to industry sources, the commercial performance of the second film has left studio executives hesitant to proceed with the concluding chapter, potentially leaving the saga unfinished.
Financial Shortfall Creates Hesitation
The zombie horror sequel 28 Years Later: The Bone Temple, directed by Nia DaCosta, has reportedly grossed approximately $57 million worldwide against a production budget of $63 million since its release last month. Despite earning strong critical reviews for its ambitious approach, the film's financial performance has fallen short of expectations. This commercial disappointment has reportedly made Sony, which acquired the franchise rights in a competitive 2024 bidding war, reluctant to greenlight the third film that was confirmed to be in development just last December.
From Breakout Success to Uncertain Future
The franchise began with the groundbreaking 2002 film 28 Days Later, directed by Danny Boyle and written by Alex Garland, which redefined the zombie genre with its fast-moving, rage-infected monsters and launched Cillian Murphy's career. That low-budget sensation grossed over $82 million worldwide from just an $8 million budget. The 2007 sequel 28 Weeks Later continued the commercial success despite lacking the original creative team.
After nearly two decades, Boyle and Garland reunited for 2024's 28 Years Later, intended as the first chapter in a new trilogy. That revival earned over $150 million globally but divided audiences with its shift toward post-apocalyptic character drama rather than traditional zombie horror. The Bone Temple continued this tonal evolution, with critics praising its ambition even as it failed to become a box office smash.
Creative Vision Versus Commercial Reality
Both Danny Boyle and Cillian Murphy had previously acknowledged in interviews that the trilogy's completion would depend on the financial performance of the first two films. The creative team had described the project from the outset as a planned trilogy with a clear story arc, with Garland having begun writing the third script last year and Boyle expressing keen interest in directing.
The final scenes of The Bone Temple specifically teased Murphy's return as protagonist Jim in a much larger capacity, setting him up to potentially headline the concluding chapter. Now, that carefully planned narrative conclusion appears in jeopardy.
Potential Lifelines and Industry Context
There may yet be hope for the franchise's completion. Netflix has reportedly expressed interest in taking on the final film, though Boyle is said to prefer a traditional theatrical release for the concluding chapter rather than sending it directly to streaming.
The struggles of The Bone Temple reflect broader challenges in the horror genre at the box office. Other anticipated horror releases, including Return to Silent Hill and The Strangers: Chapter 3, have also reportedly underperformed both critically and commercially this year.
Fan Disappointment and Unfinished Business
For dedicated fans who have followed the rage virus saga from its explosive 2002 beginnings through its ambitious revival, the possibility of the trilogy ending unfinished represents a significant disappointment. While no official cancellation has been announced, the franchise's future now appears to hinge on whether any studio is willing to take a final gamble on bringing Jim's story and the infected world to a definitive close.
The situation highlights the ongoing tension between artistic vision and commercial realities in modern filmmaking, particularly for franchises with dedicated fan bases but uncertain box office prospects. As the industry watches closely, the fate of one of horror's most influential modern franchises hangs in the balance.
